Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.73B |
| 2 |
Microsoft
MSFT
|
+$1.25B |
| 3 |
Amgen
AMGN
|
+$1.09B |
| 4 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$444M |
| 5 |
UnitedHealth
UNH
|
+$407M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$897M |
| 2 |
CERN
Cerner Corp
CERN
|
+$863M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$538M |
| 4 |
AT&T
T
|
+$392M |
| 5 |
COHR
Coherent Inc
COHR
|
+$318M |
Sector Composition
| 1 | Technology | 18.17% |
| 2 | Healthcare | 10.83% |
| 3 | Financials | 9.91% |
| 4 | Consumer Discretionary | 8.91% |
| 5 | Industrials | 5.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4701
UFP Technologies
UFPT
$1.54B
| $239K | ﹤0.01% |
3,002
-170
| -5% | -$13.5K |
|
4702
Cosan
CSAN
$2.57B
| $238K | ﹤0.01% |
17,099
-249
| -1% | -$3.47K |
|
|
BLUA
4703
DELISTED
BlueRiver Acquisition Corp.
BLUA
| $238K | ﹤0.01% |
24,172
| – | – |
|
|
RUBY
4704
DELISTED
Rubius Therapeutics, Inc
RUBY
| $238K | ﹤0.01% |
278,908
-105,845
| -28% | -$90.3K |
|
4705
StealthGas
GASS
$271M
| $237K | ﹤0.01% |
+73,875
| New | +$237K |
|
4706
Nuveen Short-Term REIT ETF
NURE
$34.2M
| $237K | ﹤0.01% |
+7,363
| New | +$237K |
|
4707
BARK
BARK
$150M
| $236K | ﹤0.01% |
184,359
-120,797
| -40% | -$155K |
|
4708
Colony Bankcorp
CBAN
$304M
| $236K | ﹤0.01% |
15,618
-23,105
| -60% | -$349K |
|
|
CMCT
4709
Creative Media & Community Trust
CMCT
$6M
| $236K | ﹤0.01% |
136
-49
| -26% | -$85K |
|
4710
Riverview Bancorp
RVSB
$102M
| $236K | ﹤0.01% |
35,852
-5,408
| -13% | -$35.6K |
|
4711
Solid Biosciences
SLDB
$420M
| $236K | ﹤0.01% |
25,535
+2,041
| +9% | +$18.9K |
|
|
DBD
4712
DELISTED
Diebold Nixdorf Incorporated
DBD
| $236K | ﹤0.01% |
104,299
-307,193
| -75% | -$695K |
|
4713
Rocky Brands
RCKY
$215M
| $235K | ﹤0.01% |
6,876
+871
| +15% | +$29.8K |
|
|
SYRS
4714
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $234K | ﹤0.01% |
24,307
+2,647
| +12% | +$25.5K |
|
|
FOVL
4715
DELISTED
iShares Focused Value Factor ETF
FOVL
| $233K | ﹤0.01% |
4,765
-18,000
| -79% | -$880K |
|
4716
Prelude Therapeutics
PRLD
$64M
| $232K | ﹤0.01% |
44,295
+20,205
| +84% | +$106K |
|
4717
FT Vest US Equity Deep Buffer ETF April
DAPR
$288M
| $231K | ﹤0.01% |
7,918
-18,082
| -70% | -$528K |
|
4718
Ventyx Biosciences
VTYX
$164M
| $231K | ﹤0.01% |
+18,868
| New | +$231K |
|
4719
Rapid Micro Biosystems
RPID
$134M
| $230K | ﹤0.01% |
53,490
+22,545
| +73% | +$96.9K |
|
4720
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$164M
| $230K | ﹤0.01% |
+7,410
| New | +$230K |
|
4721
Euroseas
ESEA
$448M
| $229K | ﹤0.01% |
11,757
-1,304
| -10% | -$25.4K |
|
4722
Security National Financial
SNFCA
$237M
| $229K | ﹤0.01% |
31,326
-893
| -3% | -$6.53K |
|
|
EMAN
4723
DELISTED
eMagin Corporation
EMAN
| $229K | ﹤0.01% |
352,247
-1,569,102
| -82% | -$1.02M |
|
4724
Mistras Group
MG
$299M
| $228K | ﹤0.01% |
38,402
-67
| -0.2% | -$398 |
|
4725
Harvard Bioscience
HBIO
$19.7M
| $227K | ﹤0.01% |
63,018
-30,718
| -33% | -$111K |
|